Candide cutaneous powder 1% bottle 30 g

Candide cutaneous powder is used to treat fungal diseases of the skin and mucous membranes caused by pathogens sensitive to clotrimazole. Tinea versicolor, erythrasma.

Composition

Active ingredient: clotrimazole;

1 g of powder contains clotrimazole 10 mg;

Excipients: talc, corn starch, colloidal anhydrous silicon dioxide, cosmetic fragrance.

Contraindication

Hypersensitivity to clotrimazole or to other components of the drug. Hypersensitivity to other imidazoles.

Method of administration and doses

Before applying the powder, wash the affected area (using soap with a neutral pH value) and dry it. Treat the affected area prepared in this way with the powder.

Adults should apply Candid powder to the affected areas 2-3 times a day until the symptoms of the disease disappear. The disappearance of symptoms is expected after a course of treatment for the following period:

After the disappearance of subjective symptoms, to ensure the effectiveness of treatment, depending on the disease, it is necessary to continue using the drug for another 2 weeks.

Application features

Pregnant women

Clinical studies on the effect of clotrimazole on fertility in women have not been conducted, however, animal studies have not shown an effect of clotrimazole on fertility.

There are limited studies of clotrimazole during pregnancy. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of clotrimazole during the first trimester of pregnancy.

Breastfeeding should be discontinued during treatment with clotrimazole.

Children

There is no experience with the use of Candid powder for the treatment of children, so it should not be used in this category of patients.

Drivers

Does not affect.

Overdose

There is no risk of acute intoxication, as overdose is unlikely to occur after a single vaginal dose or cutaneous application (application to large areas of skin under conditions conducive to increased absorption), or after accidental oral administration. There is no specific antidote.

In the event of accidental oral ingestion, gastric lavage may rarely be necessary if a life-threatening dose has been administered within the previous hour or if there are visible symptoms of overdose (e.g. dizziness, nausea or vomiting). Gastric lavage should only be performed if adequate respiratory protection is available.

Adverse reactions

From the immune system.

Allergic reactions, including discomfort, anaphylactic/anaphylactoid reactions (anaphylactic shock, angioedema, hypotension, fainting, dyspnoea, urticaria), syncope.

On the skin and subcutaneous tissue.

Redness, blistering, peeling, burning/heat sensation, tingling, local swelling, itching, rash, general irritation, pain/discomfort, peeling/exfoliation, feeling of dryness; allergic, contact dermatitis.

The appearance of these symptoms requires discontinuation of treatment with the drug.

Interaction

Clotrimazole inhibits the action of other antifungal drugs for external use, in particular amphotericin, nystatin and natamycin.

The antimicrobial effect of clotrimazole is enhanced by high concentrations of hydroxybenzoic acid propyl ester.

Dexamethasone in high doses inhibits the antifungal effect of clotrimazole.

Storage conditions

Store in a place protected from light at a temperature not exceeding 25 ° C. Keep out of the reach of children.

Shelf life - 4 years.